Cargando…

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy

Androgen receptor (AR) signaling remains the major oncogenic pathway in prostate cancer (PCa). Androgen-deprivation therapy (ADT) is the principle treatment for locally advanced and metastatic disease. However, a significant number of patients acquire treatment resistance leading to castration resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cucchiara, Vito, Yang, Joy C., Mirone, Vincenzo, Gao, Allen C., Rosenfeld, Michael G., Evans, Christopher P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295780/ https://www.ncbi.nlm.nih.gov/pubmed/28275218 http://dx.doi.org/10.3390/cancers9010009

Ejemplares similares

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
por: Liu, Chengfei, et al.
Publicado: (2021)

LncRNA-Dependent Mechanisms of Androgen Receptor-regulated Gene Activation Programs
por: Yang, Liuqing, et al.
Publicado: (2013)

Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
por: Chung, Wei-Min, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer
por: Lim, Syer C., et al.
Publicado: (2021)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
por: Wang, Junjian, et al.
Publicado: (2016)

Regulation of androgen receptor variants in prostate cancer
por: Zhu, Yezi, et al.
Publicado: (2020)

Androgen receptor co-regulation in prostate cancer
por: Senapati, Dhirodatta, et al.
Publicado: (2020)

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2018)

Androgen receptor signaling in prostate cancer development and progression
por: Lonergan, Peter E, et al.
Publicado: (2011)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
por: Xu, Pengfei, et al.
Publicado: (2023)

Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
por: Tanner, Matthew J., et al.
Publicado: (2011)

Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
por: Lavery, Derek N., et al.
Publicado: (2011)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019)

Loss and revival of androgen receptor signaling in advanced prostate cancer
por: Formaggio, Nicolò, et al.
Publicado: (2021)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
por: Messner, Elisabeth A., et al.
Publicado: (2020)

Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
por: Aksoy, Osman, et al.
Publicado: (2020)

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing
por: Shah, Kalpit, et al.
Publicado: (2020)

Serotonin regulates prostate growth through androgen receptor modulation
por: Carvalho-Dias, Emanuel, et al.
Publicado: (2017)

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
por: Zadra, Giorgia, et al.
Publicado: (2019)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015)

Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
por: Lee, Eugine, et al.
Publicado: (2015)

Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate
por: Olokpa, Emuejevoke, et al.
Publicado: (2017)

Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
por: Asangani, Irfan, et al.
Publicado: (2021)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells
por: Margiotti, Katia, et al.
Publicado: (2007)

Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer
por: Han, W, et al.
Publicado: (2018)

Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2016)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jbjrco68qnksh2dfvgm1ufiio